AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Deutsche Bank AG

Capital/Financing Update Jun 22, 2020

99_rns_2020-06-22_167c4ef5-0888-4b95-af1d-cf7e64235902.html

Capital/Financing Update

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7068Q

Deutsche Bank AG, Frankfurt

22 June 2020

22-Jun-20

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in

which such distribution would be unlawful.

Fresenius Medical Care AG & Co KGaA

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 19/05/201 Deutsche Bank AG (contact: DCM Syndication TA; telephone: 0207 54 54153 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority)2 was undertaken by the Stabilisation Manager(s)3 named below in relation to the offer of the following securities.

The Securities:

Issuer:                                                                             Fresenius Medical Care AG & Co KGaA

Guarantor (if any):                                                        Fresenius Medical Care Holdings, Inc.

Aggregate nominal amount:                                       EUR 1.25 Billion

Description:                                                                   Fresenius Medical Care 6yr & 10yr EUR1.25bn dual-tranche

Stabilisation Manager(s):                                            Commerzbank, Deutsche Bank, Mizuho, Societe       Generale                          

Offer Price:                                                                     99.405% / 99.742%

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

STAEASKAASNEEFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.